These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21555998)

  • 1. Induced pluripotent stem cells as a next-generation biomedical interface.
    Hankowski KE; Hamazaki T; Umezawa A; Terada N
    Lab Invest; 2011 Jul; 91(7):972-7. PubMed ID: 21555998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comment on pluripotent stem cells in next-generation biomedical theranostics.
    Rossbach M
    Curr Mol Med; 2013 Jun; 13(5):879-83. PubMed ID: 23642068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise Review: Induced Pluripotent Stem Cell Research in the Era of Precision Medicine.
    Hamazaki T; El Rouby N; Fredette NC; Santostefano KE; Terada N
    Stem Cells; 2017 Mar; 35(3):545-550. PubMed ID: 28100040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
    Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
    Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
    Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
    Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical guide to induced pluripotent stem cell research using patient samples.
    Santostefano KE; Hamazaki T; Biel NM; Jin S; Umezawa A; Terada N
    Lab Invest; 2015 Jan; 95(1):4-13. PubMed ID: 25089770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
    Sayed N; Liu C; Wu JC
    J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
    Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
    J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling different types of diabetes using human pluripotent stem cells.
    Abdelalim EM
    Cell Mol Life Sci; 2021 Mar; 78(6):2459-2483. PubMed ID: 33242105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application.
    Takayama N; Eto K
    Cell Mol Life Sci; 2012 Oct; 69(20):3419-28. PubMed ID: 22527724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human organs in pigs via interspecies blastocyst complementation.
    Wu J; Platero Luengo A; Gil MA; Suzuki K; Cuello C; Morales Valencia M; Parrilla I; Martinez CA; Nohalez A; Roca J; Martinez EA; Izpisua Belmonte JC
    Reprod Domest Anim; 2016 Oct; 51 Suppl 2():18-24. PubMed ID: 27762052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward Precision Medicine with Human Pluripotent Stem Cells for Diabetes.
    Memon B; Abdelalim EM
    Stem Cells Transl Med; 2022 Jul; 11(7):704-714. PubMed ID: 35640144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of mice derived from induced pluripotent stem cells.
    Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
    J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the potential of induced pluripotent stem cells for regenerative medicine.
    Wu SM; Hochedlinger K
    Nat Cell Biol; 2011 May; 13(5):497-505. PubMed ID: 21540845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.